[45F6-45F6];[46B4-46B4];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
45F6;46B4
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Presence of P+PBac{XP5.WH5}BSC132 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(2R)BSC132 predicted from the transposable element insertions sites are 45F6;46B4.